This inventor holds 111 USPTO granted patents and 33 published patent applications, plus 7 CIPO patents and 35 EPO patents, primarily in Immunogenic Compositions (CPC class 4353201). Top assignees: Eniricerche S.p.a., Novartis Ag, Glaxosmithkline Biologicals Sa. Active years: 1986-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Inventors with similar research interests:
Location History:
- Segrate - San Felice, IT (1995 - 1999)
- Segrate (MI), IT (2013 - 2015)
- Segratf, IT (2011 - 2016)
- Milan, IT (1993 - 2019)
- Siena, IT (2004 - 2020)
- Segrate, IT (1986 - 2021)
- Povo, IT (2021)
Company Filing History:
27 out of 260 
25 out of 3,978 
24 out of 545 
Years Active: 1986-2026
Areas of Expertise:
Title: Guido Grandi: Pioneering Innovations in Immunogenic Compositions
Introduction:
Guido Grandi, a prolific inventor hailing from Segrate, Italy, has made significant contributions to the world of inventions with his unwavering dedication to innovation. With an impressive portfolio of 110 patents, Grandi's work transcends boundaries and continues to inspire future generations of inventors.
Latest Patents:
1. Immunogenic compositions containing bacterial outer membrane vesicles and therapeutic uses thereof: Grandi's groundbreaking invention provides immunogenic compositions designed to stimulate an immune response against tumors in subjects. These compositions contain bacterial outer membrane vesicles loaded with tumor antigens and fusion proteins, aiding in both the prevention and treatment of tumors.
2. Immunogenic compositions containing bacterial outer membrane vesicles: This invention focuses on outer membrane vesicles from Gram-negative bacteria, comprising heterologous proteins or immunogenic fragments. These vesicles have the ability to elicit an immune response when administered to mammals, presenting a novel approach to immunotherapy.
Career Highlights:
Grandi's illustrious career includes collaborations with renowned companies such as Eni ricerca S.p.a. and Novartis AG, where he has applied his expertise in inventing novel immunogenic solutions. Throughout his career, Grandi has been at the forefront of innovative patent applications, revolutionizing the field of immunotherapy.
Collaborations:
Collaborating closely with esteemed colleagues like Maria Scarselli and Vega Masignani, Grandi has fostered a culture of innovation and excellence. Together, they have paved the way for cutting-edge developments in immunogenic compositions, driving the field forward with their collaborative efforts.
Conclusion:
In conclusion, Guido Grandi's exceptional contributions to the world of inventions stand as a testament to his pioneering spirit and creative vision. His innovative work in developing immunogenic compositions has not only advanced the field of immunotherapy but also inspired a new wave of inventors to push the boundaries of what is possible. Grandi's legacy serves as a beacon of hope for the future of medical inventions and underscores the profound impact of innovation on improving human health and well-being.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile